Study ID: BDP-AR-201

Study Title

Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR

Teva Identifier

BDP-AR-201

ClinicalTrials.gov Identifier

NCT00854360

Study Status

Completed

Trial Condition(s)

Seasonal Female, Maleergic Rhinitis | Hayfever

Interventions

Drug: Beclomethasone dipropionate HFA Nasal Aerosol | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender

Female, Male

Age Range

12 Years and older

Trial Duration

03/01/2009 - 05/01/2009

Phase

Phase 2

Study Type

Interventional